Januvia and Abdominal mass - a phase IV clinical study of FDA data


Abdominal mass is found among people who take Januvia, especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months.

The phase IV clinical study analyzes which people take Januvia and have Abdominal mass. It is created by eHealthMe based on reports of 62,758 people who have side effects when taking Januvia from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jul, 04, 2022

62,758 people reported to have side effects when taking Januvia.
Among them, 27 people (0.04%) have Abdominal mass.

What is Januvia?

Januvia has active ingredients of sitagliptin phosphate. It is often used in diabetes. eHealthMe is studying from 63,859 Januvia users for its effectiveness, alternative drugs and more.

What is Abdominal mass?

Abdominal mass (localized enlargement or swelling in the human abdomen) is found to be associated with 1,360 drugs and 832 conditions by eHealthMe.

Number of Januvia and Abdominal mass reports submitted per year:

Could Januvia cause Abdominal mass?

Time on Januvia when people have Abdominal mass *:

  • < 1 month: 11.11 %
  • 1 - 6 months: 33.33 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 33.33 %
  • 2 - 5 years: 22.22 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Abdominal mass when taking Januvia *:

  • female: 65.38 %
  • male: 34.62 %

Age of people who have Abdominal mass when taking Januvia *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 18.18 %
  • 50-59: 27.27 %
  • 60+: 54.55 %

Common drugs people take besides Januvia *:

  1. Crestor: 8 people, 29.63%
  2. Metformin: 7 people, 25.93%
  3. Percocet: 6 people, 22.22%
  4. Symbicort: 6 people, 22.22%
  5. Imitrex: 6 people, 22.22%
  6. Valtrex: 5 people, 18.52%
  7. Nucynta: 5 people, 18.52%
  8. Eliquis: 5 people, 18.52%
  9. Prilosec: 4 people, 14.81%
  10. Aspirin: 3 people, 11.11%

Common side effects people have besides Abdominal mass *:

  1. Depression: 6 people, 22.22%
  2. Abdominal Distension: 6 people, 22.22%
  3. Infusion Site Rash: 5 people, 18.52%
  4. High Blood Pressure: 5 people, 18.52%
  5. Weakness: 5 people, 18.52%
  6. Breathing Difficulty: 5 people, 18.52%
  7. Pleural Effusion (water on the lungs): 4 people, 14.81%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 14.81%
  9. Infusion Site Extravasation (flow of (blood or lymph) from infusion site): 4 people, 14.81%
  10. Infusion Site Mass: 4 people, 14.81%

Common conditions people have *:

  1. Rhinitis (a medical term for irritation and inflammation of the mucous membrane inside the nose): 5 people, 18.52%
  2. High Blood Cholesterol: 5 people, 18.52%
  3. Immunodeficiency Common Variable: 5 people, 18.52%
  4. Stress And Anxiety: 3 people, 11.11%
  5. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 7.41%
  6. Pancreatic Disorder: 2 people, 7.41%
  7. High Blood Pressure: 2 people, 7.41%
  8. Depression: 2 people, 7.41%
  9. Crohn's Disease (condition that causes inflammation of the gastrointestinal tract): 2 people, 7.41%
  10. Urination - Painful: 1 person, 3.70%

* Approximation only. Some reports may have incomplete information.

Do you take Januvia and have Abdominal mass?

Check whether Abdominal mass is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

How severe was Abdominal mass and when was it recovered:

Expand to all the drugs that have ingredients of sitagliptin phosphate:

Alternative drugs to, pros and cons of Januvia:

Common Januvia side effects:

Browse all side effects of Januvia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Abdominal mass treatments and more:

COVID vaccines that are related to Abdominal mass:

Common drugs associated with Abdominal mass:

All the drugs that are associated with Abdominal mass:

Common conditions associated with Abdominal mass:

All the conditions that are associated with Abdominal mass:

How the study uses the data?

The study uses data from the FDA. It is based on sitagliptin phosphate (the active ingredients of Januvia) and Januvia (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: